UK’s ‘Pioneering’ Medicines Repurposing Program Delivers First License

 
• By Neena Brizmohun

Now that the first license for a drug has been obtained in partnership with the program, work will begin to ensure other companies that make the product adopt the new licensed indication.

Anastrozole is now approved in the UK for use as a preventive treatment for breast cancer • Source: Shutterstock

More from United Kingdom

More from Europe